X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
AMAR REMEDIES Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES Quarterly Results   (AMAD)

Here are the latest quarterly results of AMAR REMEDIES. For more details, see the AMAR REMEDIES financial fact sheet and AMAR REMEDIES share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

AMAR REMEDIES Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-11
3
Dec-11
3
Mar-12
3
Jun-12
3
Sep-12
3
Dec-12
3
Mar-13
3
Jun-13
8-Qtr Chart
Click to enlarge
Net Sales Rs m1,5911,6491,6931,8111,5241,6301,310452 
Other income Rs m014525420 
Turnover Rs m1,5911,6631,6981,8131,5291,6341,312452 
Expenses Rs m1,3591,4051,4131,4371,3631,4471,219531 
Gross profit Rs m23224427937316018391-80 
Depreciation Rs m2828284331474721 
Interest Rs m8890104116119124139146 
Profit before tax Rs m1161401522161516-93-247 
Tax Rs m181823643300 
Profit after tax Rs m981221291521213-93-247 
Gross profit margin %14.614.816.520.610.511.26.9-17.7 
Effective tax rate %15.512.915.129.620.018.80.00.0 
Net profit margin %6.27.47.68.40.80.8-7.1-54.6 
Diluted EPS Rs 3.7 4.7 4.9 5.8 0.5 0.5 -3.6 -9.4  
Diluted EPS (TTM) Rs 15.0 16.1 17.3 19.2 15.9 11.7 3.2 -12.0  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Consumer Products Company Quarterly Results:   INDRAPRASTHA MEDICAL  FULFORD INDIA  BIOCON   NATCO PHARMA  FRESENIUS KABI ONCO.  

Compare AMAR REMEDIES With:   INDRAPRASTHA MEDICAL  FULFORD INDIA  BIOCON   NATCO PHARMA  FRESENIUS KABI ONCO.  

Compare AMAR REMEDIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Rising Oil Prices, Latest on the Jet Airways Saga, and Top Stocks in Action Today(Pre-Open)

On Tuesday, share markets in India fell sharply in the afternoon session and ended deep in the red after a volatile day of trading.

Views on news

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

More Views on News

Most Popular

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

A Simple Checklist for Picking Great Dividend Stocks(Profit Hunter)

May 9, 2019

A filtered, neat list of high-dividend stocks with all this dirty work already done for you.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AMAR REMEDIES

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS